Therefore, exploring the immunological characteristics of convalescent COVID‐19 patients will help to understand the impact of SARS‐CoV‐2 infections on adaptive immune responses more comprehensively, and the diversity of TCR and BCR will provide valuable insights into the dynamic change of immune function in convalescent COVID‐19 patients. This evidence concerns the gene BCR and COVID-19.